Illumina Inc (ILMN)

175.29
NASDAQ : Health Care
Prev Close 177.16
Day Low/High 173.59 / 177.23
52 Wk Low/High 119.37 / 186.88
Avg Volume 925.20K
Exchange NASDAQ
Shares Outstanding 146.00M
Market Cap 25.87B
EPS 3.10
P/E Ratio 57.71
Div & Yield N.A. (N.A)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: GSBD, HYH, ILMN, IMH, RICE, WBC Downgrades: CAFD, HIIQ Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Apple's Streaming Aspirations Not Enough to Get by Facebook: Challenge Update

Apple's Streaming Aspirations Not Enough to Get by Facebook: Challenge Update

Here are the highlights from the final round of our Market Bracket Challenge tournament.

(Graphic: Business Wire)

(Graphic: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) today announced it is contributing more than 8,000 associations of somatic genetic alterations—variants linked to tumors—to the Clinical Interpretation of Variants in Cancer...

Apple Walks All Over Nike, Facebook and Illumina Square Off: Challenge Update

Apple Walks All Over Nike, Facebook and Illumina Square Off: Challenge Update

Here are the highlights from the fifth round of our tournament, which will end with an epic tech clash between Apple and Facebook.

Here Are Some of the Top Health Care Stocks in the First Quarter

Here Are Some of the Top Health Care Stocks in the First Quarter

Illumina, Centene, Community Health, Incyte and Vertex were among the healthcare stocks that did well in the first quarter.

Nike, Apple, Illumina and Facebook Take Last 4 Spots in TheStreet's Market Bracket Challenge

Nike, Apple, Illumina and Facebook Take Last 4 Spots in TheStreet's Market Bracket Challenge

Nike, Apple, Illumina and Facebook take the last four spots in TheStreet's Market Bracket Challenge.

Facebook Squanders Snap's Title Hopes, Nike Advances: Challenge Update

Facebook Squanders Snap's Title Hopes, Nike Advances: Challenge Update

Here's your update through four rounds of action in TheStreet's Market Bracket Challenge.

Snap Continues to Prove Committee Wrong; Apple Hangs on in Duel With Micron -- Bracket Update

Snap Continues to Prove Committee Wrong; Apple Hangs on in Duel With Micron -- Bracket Update

Here's your update through three rounds of action in TheStreet's Market Bracket Challenge.

Illumina Becomes #84 Most Shorted S&P 500 Component, Replacing Public Storage

Illumina Becomes #84 Most Shorted S&P 500 Component, Replacing Public Storage

The most recent short interest data has been released for the 03/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Snap's Cinderella Story Continues to Unfold as Nike Squeaks By AT&T: An Update From the Challenge

Snap's Cinderella Story Continues to Unfold as Nike Squeaks By AT&T: An Update From the Challenge

It has been a wild ride through two rounds of action.

Snap Pulls Off Miracle, Can the Good Times Continue? An Update From the Challenge

Snap Pulls Off Miracle, Can the Good Times Continue? An Update From the Challenge

It has been a wild ride thus far, and we've only completed one round of action.

Here's a Look at the 64 Best Performing Stocks Over the Last 4 Months

Here's a Look at the 64 Best Performing Stocks Over the Last 4 Months

The top 64 companies taking a trip to TheStreet's 2017 Market Bracket Challenge tournament.

Weekly Roundup

Fed's rate hike gives markets a midweek boost. In the portfolio, we trim 1 position and add to 3 others.

Illumina Becomes #21 Most Shorted Nasdaq 100 Component, Replacing Yahoo!

Illumina Becomes #21 Most Shorted Nasdaq 100 Component, Replacing Yahoo!

The most recent short interest data has been released for the 02/28/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Munich Leukemia Laboratory Selects IBM Watson And Illumina For Research Collaboration To Improve Diagnostics And Develop Personalized Treatment Tools For Leukemia & Lymphoma

Munich Leukemia Laboratory Selects IBM Watson And Illumina For Research Collaboration To Improve Diagnostics And Develop Personalized Treatment Tools For Leukemia & Lymphoma

Munich Leukemia Laboratory (MLL), a state-of-the-art leukemia and lymphoma diagnostic and research laboratory based in Munich, has teamed up with IBM (NYSE: IBM) and Illumina, Inc.

Illumina Announces The IHope Network, An Expansion Of Its IHope Philanthropic Clinical Whole Genome Sequencing Program

Illumina Announces The IHope Network, An Expansion Of Its IHope Philanthropic Clinical Whole Genome Sequencing Program

Illumina, Inc. (NASDAQ:ILMN) today announced the launch of the iHope Network, a consortium of member institutions who have committed to providing clinical whole genome sequencing (cWGS) to underserved families.

Is Illumina On The Verge of a Breakout?

Is Illumina On The Verge of a Breakout?

Following yesterday's 4.25% gain shares of Illumina are set up well for an upside breakout.

Illumina To Webcast Live Presentation At The Cowen And Company Annual Health Care Conference

Illumina To Webcast Live Presentation At The Cowen And Company Annual Health Care Conference

Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company's presentation at the Cowen and Company 37 th Annual Health Care Conference in Boston, Massachusetts on March 7,...

John Thompson (Photo: Business Wire)

John Thompson (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) announced today that John W.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Illumina, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of February 14, 2017 - ILMN

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Illumina, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of February 14, 2017 - ILMN

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Illumina, Inc.

ILMN SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Illumina, Inc. And A Lead Plaintiff Deadline Of February 14, 2017

ILMN SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Illumina, Inc. And A Lead Plaintiff Deadline Of February 14, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of California on behalf of investors who purchased Illumina, Inc.

Illumina Reports Full Financial Results For Fourth Quarter And Fiscal Year 2016

Illumina Reports Full Financial Results For Fourth Quarter And Fiscal Year 2016

Illumina, Inc. (NASDAQ:ILMN) today announced its full financial results for the fourth quarter and fiscal year 2016.

Illumina Debuts VeriSeq™ Analysis Software (48 Samples), Optimized Data Analysis For Noninvasive Prenatal Testing

Illumina Debuts VeriSeq™ Analysis Software (48 Samples), Optimized Data Analysis For Noninvasive Prenatal Testing

Illumina, Inc. (NASDAQ: ILMN) today announced that it has declared conformity with the requirements of the IVD Directive and has applied the CE mark to an expanded VeriSeq™ NIPT Analysis Software for clinical...

Caroline Dorsa (Photo: Business Wire)

Caroline Dorsa (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) announced today that Caroline Dorsa has joined the company's Board of Directors.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Illumina, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of February 14, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Illumina, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of February 14, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Illumina, Inc.